The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma

S. K. Martin, P. Diamond, S. Gronthos, D. J. Peet, A. C W Zannettino

Research output: Contribution to journalReview article

82 Citations (Scopus)


Hypoxia is an imbalance between oxygen supply and demand, which deprives cells or tissues of sufficient oxygen. It is well-established that hypoxia triggers adaptive responses, which contribute to short-and long-term pathologies such as inflammation, cardiovascular disease and cancer. Induced by both microenvironmental hypoxia and genetic mutations, the elevated expression of the hypoxia-inducible transcription factor-1 (HIF-1) and HIF-2 is a key feature of many human cancers and has been shown to promote cellular processes, which facilitate tumor progression. In this review, we discuss the emerging role of hypoxia and the HIFs in the pathogenesis of multiple myeloma (MM), an incurable hematological malignancy of BM PCs, which reside within the hypoxic BM microenvironment. The need for current and future therapeutic interventions to target HIF-1 and HIF-2 in myeloma will also be discussed.

Original languageEnglish
Pages (from-to)1533-1542
Number of pages10
Issue number10
Publication statusPublished - 1 Jan 2011


  • HIF-1
  • HIF-2
  • hypoxia
  • multiple myeloma

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this